Core Technical Competencies


Baxter has pioneered and utilized a range of sterilization platforms to meet the unique requirements and characteristics of its biopharmaceutical, IV and injectable pharmaceutical and medical device products.  These technologies include the use of steam or heat, ethylene oxide, gamma and electron-beam radiation to sterilize finished product, and the use of proprietary in-line technologies for aseptic manufacturing.  Baxter's technology is the only commercially available aseptic filling process for premixed drugs in flexible IV bags.  In 2005, Baxter combined this proprietary flexible plastic container technology with its expertise in biologics to introduce the world's first albumin (a plasma-based protein) in a flexible plastic container.  Baxter's sterilization capabilities include systems for validation and assurance, and development of novel chemical and biological indicators and barrier technologies.